References
- Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008;122:360-7. https://doi.org/10.1542/peds.2007-2767
- Leaute-Labreze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017;390:85-94. https://doi.org/10.1016/S0140-6736(16)00645-0
- Garzon MC, Frieden IJ. Hemangiomas: when to worry. Pediatr Ann 2000;29:58-67. https://doi.org/10.3928/0090-4481-20000101-10
- Jung HL. Update on infantile hemangioma. Clin Exp Pediatrics 2021;64:559-72. https://doi.org/10.3345/cep.2020.02061
- Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. https://doi.org/10.1056/NEJMc0708819
- Leaute-Labreze C, Hoeger P, Mazereeuw-Hautier J, Guibaud L, Baselga E, Posiunas G, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med 2015;372:735-46. https://doi.org/10.1056/NEJMoa1404710
- Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013;131:128-40. https://doi.org/10.1542/peds.2012-1691
- Bagazgoitia L, Hernandez-Martin A, Torrelo A. Recurrence of infantile hemangiomas treated with propranolol. Pediatr Dermatol 2011;28:658-62. https://doi.org/10.1111/j.1525-1470.2011.01644.x
- Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, et al. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2014;140:323-30. https://doi.org/10.1001/jamaoto.2013.6723